Open Market Insiders Trades
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
NFLX
|
Reed Hastings
Executive Chairman |
SELL
Open market or private sale
|
Direct | 32,067 Reduced 98.92% |
$31,313,104
$976.49 p/Share
|
Feb 03
2025 |
|
GWRE
|
Michael George Rosenbaum
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 1,400 Reduced 0.5% |
$291,788
$208.42 p/Share
|
Feb 03
2025 |
|
GWRE
|
John P Mullen
President |
SELL
Open market or private sale
|
Direct | 3,000 Reduced 1.69% |
$627,630
$209.21 p/Share
|
Feb 03
2025 |
|
ARQT
|
Larry Todd Edwards
Officer |
SELL
Open market or private sale
|
Direct | 2,173 Reduced 1.58% |
$27,597
$12.7 p/Share
|
Feb 03
2025 |
|
ARQT
|
Patrick Burnett
Officer |
SELL
Open market or private sale
|
Direct | 12,116 Reduced 9.54% |
$153,873
$12.7 p/Share
|
Feb 03
2025 |
|
ARQT
|
Howard G. Welgus
Director |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 6.58% |
$127,100
$12.71 p/Share
|
Feb 03
2025 |
|
ARQT
|
Todd Franklin Watanabe
Director |
SELL
Open market or private sale
|
Direct | 19,301 Reduced 2.34% |
$245,122
$12.7 p/Share
|
Feb 03
2025 |
|
ARQT
|
Masaru Matsuda
Officer |
SELL
Open market or private sale
|
Direct | 8,338 Reduced 4.46% |
$105,892
$12.7 p/Share
|
Feb 03
2025 |
|
RSI
|
Mattias Stetz
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 25,000 Reduced 4.27% |
$360,000
$14.4 p/Share
|
Feb 03
2025 |
|
RSI
|
Einar Roosileht
Chief Information Officer |
SELL
Open market or private sale
|
Direct | 70,000 Reduced 6.89% |
$1,008,700
$14.41 p/Share
|
Feb 03
2025 |
|
SMC
|
J Heath Deneke
Chairman, President and CEO |
SELL
Open market or private sale
|
Direct | 1,000 Reduced 0.38% |
$41,040
$41.04 p/Share
|
Feb 03
2025 |
|
PCVX
|
Jim Wassil
CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct | 8,000 Reduced 3.74% |
$694,960
$86.87 p/Share
|
Feb 03
2025 |
|
BSX
|
Arthur C Butcher
EVP& Grp Pres, MedSurg & APAC |
SELL
Open market or private sale
|
Direct | 17,313 Reduced 75.88% |
$1,762,290
$101.79 p/Share
|
Feb 03
2025 |
|
ATEC
|
David Sponsel
EVP, SALES |
SELL
Open market or private sale
|
Direct | 36,256 Reduced 4.7% |
$414,043
$11.42 p/Share
|
Feb 03
2025 |
|
SEMR
|
Eugenie Levin
President |
SELL
Open market or private sale
|
Direct | 15,093 Reduced 2.97% |
$258,241
$17.11 p/Share
|
Feb 03
2025 |
|
SNOW
|
Christopher William Degnan
Chief Revenue Officer |
SELL
Open market or private sale
|
Direct | 12,782 Reduced 3.98% |
$2,306,000
$180.41 p/Share
|
Feb 03
2025 |
|
AI
|
Richard C Levin |
SELL
Open market or private sale
|
Direct | 12,000 Reduced 6.91% |
$358,080
$29.84 p/Share
|
Feb 03
2025 |
|
AAPL
|
Arthur D Levinson
Director |
SELL
Open market or private sale
|
Direct | 1,516 Reduced 0.04% |
$343,146
$226.35 p/Share
|
Feb 03
2025 |
|
TEAM
|
Scott Farquhar |
SELL
Open market or private sale
|
Indirect | 7,948 Reduced 0.0% |
$2,447,666
$307.96 p/Share
|
Feb 03
2025 |
|
TEAM
|
Michael Cannon Brookes
CEO, Co-Founder |
SELL
Open market or private sale
|
Indirect | 7,948 Reduced 0.0% |
$2,447,666
$307.96 p/Share
|
Feb 03
2025 |
|
SEMR
|
David W Mason
General Counsel |
SELL
Open market or private sale
|
Direct | 1,875 Reduced 1.17% |
$32,156
$17.15 p/Share
|
Feb 03
2025 |
|
TER
|
Mercedes Johnson
Director |
SELL
Open market or private sale
|
Direct | 625 Reduced 4.46% |
$70,362
$112.58 p/Share
|
Feb 03
2025 |
|
V
|
Julie B Rottenberg
GENERAL COUNSEL |
SELL
Open market or private sale
|
Direct | 2,572 Reduced 17.74% |
$874,480
$340.0 p/Share
|
Feb 03
2025 |
|
CIEN
|
Gary B Smith
President, CEO |
SELL
Open market or private sale
|
Direct | 6,800 Reduced 1.62% |
$577,048
$84.86 p/Share
|
Feb 03
2025 |
|
HALO
|
Jeffrey William Henderson |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 11.46% |
$280,850
$56.17 p/Share
|
Feb 03
2025 |
|
V
|
Ryan Mcinerney
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 8,620 Reduced 100.0% |
$2,930,800
$340.0 p/Share
|
Feb 03
2025 |
|
PNRG
|
Robert De Rothschild |
SELL
Open market or private sale
|
Indirect | 471 Reduced 0.0% |
$99,852
$212.0 p/Share
|
Feb 03
2025 |
|
GMGI
|
Aleksandar Milovanovic |
BUY
Open market or private purchase
|
Direct | 50,000 Added 0.06% |
$90,000
$1.8 p/Share
|
Feb 03
2025 |
|
PETS
|
Nina Capital Holdings Inc.
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 25,000 Added 1.1% |
$120,500
$4.82 p/Share
|
Feb 03
2025 |
|
AFRM
|
Keith Rabois
Director |
SELL
Open market or private sale
|
Direct | 16,086 Reduced 17.17% |
$953,578
$59.28 p/Share
|
Feb 03
2025 |
|
AKBA
|
Nicholas Grund
Chief Commercial Officer |
SELL
Open market or private sale
|
Direct | 55,621 Reduced 11.16% |
$116,804
$2.1 p/Share
|
Feb 03
2025 |
|
AKBA
|
Richard C Malabre
SVP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct | 30,202 Reduced 9.73% |
$63,424
$2.1 p/Share
|
Feb 03
2025 |
|
CRM
|
Sundeep G. Reddy
EVP & Chief Accounting Officer |
SELL
Open market or private sale
|
Direct | 500 Reduced 7.09% |
$167,970
$335.94 p/Share
|
Feb 03
2025 |
|
AKBA
|
Steven Keith Burke
SVP, Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 50,506 Reduced 5.83% |
$106,062
$2.1 p/Share
|
Feb 03
2025 |
|
SYBX
|
Mary Beth Dooley |
SELL
Open market or private sale
|
Direct | 2,107 Reduced 13.91% |
$2,802
$1.33 p/Share
|
Feb 03
2025 |
|
AKBA
|
John P. Butler
CEO and President |
SELL
Open market or private sale
|
Direct | 144,250 Reduced 5.25% |
$302,925
$2.1 p/Share
|
Feb 03
2025 |
|
NBIX
|
Ingrid Delaet
Chief Regulatory Officer |
SELL
Open market or private sale
|
Direct | 623 Reduced 15.33% |
$93,007
$149.29 p/Share
|
Feb 03
2025 |
|
CARG
|
Samuel Zales
COO and President |
SELL
Open market or private sale
|
Direct | 20,000 Reduced 4.76% |
$767,200
$38.36 p/Share
|
Feb 03
2025 |
|
MORN
|
Joseph D Mansueto
Executive Chairman |
SELL
Open market or private sale
|
Direct | 1,716 Reduced 0.02% |
$562,659
$327.89 p/Share
|
Feb 03
2025 |
|
CRM
|
Amy E Weaver
President and CFO |
SELL
Open market or private sale
|
Direct | 6,221 Reduced 11.74% |
$2,089,882
$335.94 p/Share
|
Feb 03
2025 |
|
FRSH
|
Zachary Nelson
Director |
SELL
Open market or private sale
|
Direct | 8,442 Reduced 25.87% |
$154,488
$18.3 p/Share
|
Feb 03
2025 |
|
MIRM
|
Jolanda Howe
SVP, GLOBAL CONTROLLER |
SELL
Open market or private sale
|
Direct | 1,064 Reduced 20.09% |
$51,306
$48.22 p/Share
|
Feb 03
2025 |
|
MIRM
|
Christopher Peetz
CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct | 9,102 Reduced 7.28% |
$438,898
$48.22 p/Share
|
Feb 03
2025 |
|
MIRM
|
Peter Radovich
PRESIDENT AND COO |
SELL
Open market or private sale
|
Direct | 2,627 Reduced 8.88% |
$126,673
$48.22 p/Share
|
Feb 03
2025 |
|
JCI
|
Nathan D Manning
VP, President BSNA |
SELL
Open market or private sale
|
Direct | 1,421 Reduced 0.95% |
$108,621
$76.44 p/Share
|
Feb 03
2025 |
|
SLP
|
Walter S Woltosz
Director |
SELL
Open market or private sale
|
Direct | 20,000 Reduced 0.58% |
$676,000
$33.8 p/Share
|
Feb 03
2025 |
|
CVNA
|
Mark W. Jenkins
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 4.35% |
$2,478,500
$247.85 p/Share
|
Feb 03
2025 |
|
FRSH
|
Mika Yamamoto
CHIEF CUST & MARKETING OFFICER |
SELL
Open market or private sale
|
Direct | 2,859 Reduced 0.71% |
$52,291
$18.29 p/Share
|
Feb 03
2025 |
|
GMTX
|
Rahul Khara
Chief Legal Officer |
SELL
Open market or private sale
|
Direct | 7,500 Reduced 34.83% |
$417,825
$55.71 p/Share
|
Feb 03
2025 |
|
CBSH
|
David W Kemper
Executive Chairman |
SELL
Open market or private sale
|
Direct | 3,708 Reduced 0.31% |
$245,321
$66.16 p/Share
|
Feb 03
2025 |